The Neupro 2mg brand, founded in 2008 (Germany), from 359 sister brands and 2214 competing brands. Neupro 2mg is owned by UCB, listed on the stock exchange of Bruxelles The International Securities Identification Number (ISIN) of UCB is BE0003739530. Neupro 2mg belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
UCB
(Neupro 2mg)
over 5 years*
EUR 203.59